Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of California at Davis
Davis, California
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 418
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Alyssa Panitch | Conflict of Interest | SYMIC Biomedical, Inc. | $200,000 - $249,999 | 2017 |
| Francis Peterson | Conflict of Interest | Protein Foundry | $20,000 - $39,999 | 2018 |
| Brian Volkman | Conflict of Interest | Protein Foundry, Inc | $10,000 - $19,999 | 2018 |
| William Murphy | Conflict of Interest | NIH | $5,000 - $9,999 | 2013 |
| Alyssa Panitch | Conflict of Interest | SYMIC Biomedical, Inc. | $5,000 - $9,999 | 2017 |
| Alyssa Panitch | Conflict of Interest | SYMIC Biomedical, Inc. | $5,000 - $9,999 | 2017 |
| Reginald I. Low | Financial Disclosure | Boston Scientific Corporation, Inc. | 2016 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2018 | |
| Reginald I. Low | Financial Disclosure | Boston Scientific Corporation, Inc. | 2016 | |
| David M. Asmuth | Financial Disclosure | Merck Sharp & Dohme Corp., a subsidiary of Merck | 2017 | |
| Craig McDonald | Financial Disclosure | PTC Therapeutics, Inc. | 2018 | |
| Jonathan Ducore | Financial Disclosure | Bayer Healthcare Pharmaceuticals, Inc. | 2018 | |
| Roblee Allen | Financial Disclosure | United Therapeutics Corp. | 2018 | |
| Roblee Allen | Financial Disclosure | United Therapeutics Corp. | 2018 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| Alyson E. Mitchell | Financial Disclosure | Almond Board of California | 2016 | |
| David Asmuth | Financial Disclosure | Merck Sharp & Dohme Corp. | 2018 | |
| Roblee Allen | Financial Disclosure | United Therapeutics Corp. | 2018 | |
| David Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2018 | |
| David Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2018 | |
| Robert Hackman | Financial Disclosure | Misc Spon Cat 01 (CFS Only: C&G Office Use 9850) | 2018 | |
| Craig McDonald | Financial Disclosure | PTC Therapeutics, Inc. | 2018 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| Craig McDonald | Financial Disclosure | Sarepta Therapeutics | 2018 | |
| Craig McDonald | Financial Disclosure | Capricor Therapeutics, Inc. | 2018 | |
| Craig McDonald | Financial Disclosure | Sarepta Therapeutics | 2018 | |
| Craig McDonald | Financial Disclosure | Catabasis Pharmaceuticals, Inc. | 2018 | |
| Patricia Oteiza de Fraga | Financial Disclosure | NSE Products, Inc | 2018 | |
| Robert Powell | Financial Disclosure | Lawrence Livermore National Security, LLC | 2018 | |
| William Ristenpart | Financial Disclosure | Specialty Coffee Association of America | 2018 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| Reginald I. Low | Financial Disclosure | MVRx, Inc. | 2018 | |
| Reginald I. Low | Financial Disclosure | Abbott Cardiovascular Systems, Inc. | 2018 | |
| Roblee Allen | Financial Disclosure | United Therapeutics Corp. | 2018 | |
| Craig McDonald | Financial Disclosure | PTC Therapeutics, Inc. | 2018 | |
| Craig McDonald | Financial Disclosure | Santhera Pharmaceuticals Holding AG | 2018 | |
| Craig McDonald | Financial Disclosure | PTC Therapeutics | 2018 | |
| Craig McDonald | Financial Disclosure | Capricor Therapeutics | 2018 | |
| Brian Morrissey | Financial Disclosure | Savara Inc. | 2018 | |
| Brian Morrissey | Financial Disclosure | Insmed Incorporated | 2018 | |
| Brian Morrissey | Financial Disclosure | ALung Technologies, Inc. | 2018 | |
| Ilias Tagkopoulos | Financial Disclosure | Mars | 2017 | |
| David Woodruff | Financial Disclosure | Sandia National Laboratories | 2018 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| David M. Asmuth | Financial Disclosure | Gilead Sciences, Inc. | 2017 | |
| Sarah Stewart-Mukhopadhyay | Financial Disclosure | Simons Foundation | 2018 | |
| Jonathan Ducore | Financial Disclosure | Bioverativ, Inc | 2017 | |
| Jonathan Ducore | Financial Disclosure | Bioverativ, Inc | 2017 | |
| Sarah Stewart-Mukhopadhyay | Financial Disclosure | Lawrence Livermore National Security, LLC | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.